GR1000738B - Μεθοδος παρασκευης νεων συνθεσεων αεροζολης - Google Patents

Μεθοδος παρασκευης νεων συνθεσεων αεροζολης

Info

Publication number
GR1000738B
GR1000738B GR900100428A GR900100428A GR1000738B GR 1000738 B GR1000738 B GR 1000738B GR 900100428 A GR900100428 A GR 900100428A GR 900100428 A GR900100428 A GR 900100428A GR 1000738 B GR1000738 B GR 1000738B
Authority
GR
Greece
Prior art keywords
compositions
preparation
compounds
macrocyclic compounds
alkoxy
Prior art date
Application number
GR900100428A
Other languages
English (en)
Other versions
GR900100428A (en
Inventor
Ikuo Akutsu
Takeshi Fukuda
Michael Dale Dr Jackson
Sohei Makino
Anthony Alan Norris
Original Assignee
Fisons Plc Fujisawa Pharmac Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898912935A external-priority patent/GB8912935D0/en
Priority claimed from JP2096045A external-priority patent/JPH03291225A/ja
Application filed by Fisons Plc Fujisawa Pharmac Co filed Critical Fisons Plc Fujisawa Pharmac Co
Publication of GR900100428A publication Critical patent/GR900100428A/el
Publication of GR1000738B publication Critical patent/GR1000738B/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Non-Portable Lighting Devices Or Systems Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)

Abstract

Οι ενώσεις του τύπου Ι Χ Η Μ Ι Κ Η Ε Ν Ω Σ Η εις τον οποίον τα R1 και R2 ομού παριστούν δύο γειτονικά άτομα υδρογόνου, ή σχηματίζουν ένα δεύτερο δεσμό μεταξύ των γειτονικών ατόμων άν?ρακος είς τα οποία αυτά είναι συνδεδεμένα το R3 παριστά Η,ΟΗ αλκοξυ ή προστατευόμενο υδροξυ το R4 παριστά Η ή ΟΗ το R5 παριστά Η, αλκυλ ή αλκενυλ τα R6 και R7 ανεξαρτήτως το έν του άλλου παριστουν Ο, (Η,ΟΗ), (Η προσταευόμενο υδροξυ) ή (Η, αλκοξυ) τα Χ και Υ ανεξαρτήτως το εν του άλλου παριστούν Ο,(Η,ΟΗ) ή (Η,Η), το η είναι 1 ή 2. ή φαρμακευτικώς παραγωγα αυτών δίδονται δια την αγωγή της ασ?ένειας της αντιστρεπτής αποφράξεως των αναπνευστικών οδών και ιδιαιτέρως του άσ?ματος. Αποκαλύπτονται επίσης συν?έσεις οι οποίες περιέχουν τέτοιες ενώσεις. ω
GR900100428A 1989-06-06 1990-06-06 Μεθοδος παρασκευης νεων συνθεσεων αεροζολης GR1000738B (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898912935A GB8912935D0 (en) 1989-06-06 1989-06-06 Method of treatment
JP2096045A JPH03291225A (ja) 1990-04-09 1990-04-09 抗喘息薬

Publications (2)

Publication Number Publication Date
GR900100428A GR900100428A (en) 1991-11-15
GR1000738B true GR1000738B (el) 1992-12-30

Family

ID=26295442

Family Applications (1)

Application Number Title Priority Date Filing Date
GR900100428A GR1000738B (el) 1989-06-06 1990-06-06 Μεθοδος παρασκευης νεων συνθεσεων αεροζολης

Country Status (13)

Country Link
EP (1) EP0475994B1 (el)
JP (1) JP2508918B2 (el)
KR (1) KR0147852B1 (el)
AT (1) ATE111353T1 (el)
AU (1) AU639460B2 (el)
CA (1) CA2054203C (el)
DE (1) DE69012560T2 (el)
DK (1) DK0475994T3 (el)
ES (1) ES2061043T3 (el)
GR (1) GR1000738B (el)
IE (1) IE64214B1 (el)
PT (1) PT94292B (el)
WO (1) WO1990014826A1 (el)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208228A (en) * 1989-11-13 1993-05-04 Merck & Co., Inc. Aminomacrolides and derivatives having immunosuppressive activity
US5143918A (en) * 1990-10-11 1992-09-01 Merck & Co., Inc. Halomacrolides and derivatives having immunosuppressive activity
US5147877A (en) * 1991-04-18 1992-09-15 Merck & Co. Inc. Semi-synthetic immunosuppressive macrolides
ATE198708T1 (de) * 1991-04-26 2001-02-15 Fujisawa Pharmaceutical Co Verwendung von makrolid-verbindungen gegen augenerkrankungen
US5565560A (en) * 1991-05-13 1996-10-15 Merck & Co., Inc. O-Aryl,O-alkyl,O-alkenyl and O-alkynylmacrolides having immunosuppressive activity
US5162334A (en) * 1991-05-13 1992-11-10 Merck & Co., Inc. Amino O-alkyl, O-alkenyl and O-alkynlmacrolides having immunosuppressive activity
US5250678A (en) 1991-05-13 1993-10-05 Merck & Co., Inc. O-aryl, O-alkyl, O-alkenyl and O-alkynylmacrolides having immunosuppressive activity
US5189042A (en) * 1991-08-22 1993-02-23 Merck & Co. Inc. Fluoromacrolides having immunosuppressive activity
ZA926812B (en) 1991-09-09 1993-04-28 Merck & Co Inc O-heteroaryl,o-alkylheteroaryl,o-alkenylheteroaryl and o-alkynylheteroaryl macrolides having immunosupressive activity
US5208241A (en) * 1991-09-09 1993-05-04 Merck & Co., Inc. N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n-alkynylheteroarylmacrolides having immunosuppressive activity
GB9218027D0 (en) * 1992-08-25 1992-10-14 Fisons Plc Novel method of treatment
US5693648A (en) * 1994-09-30 1997-12-02 Merck & Co., Inc. O-aryl, O-alkyl, O-alkenyl and O-alkynyl-macrolides having immunosuppressive activity
AU2002952559A0 (en) * 2002-11-08 2002-11-21 Fujisawa Pharmaceutical Co., Ltd. New use
WO2004069223A2 (en) * 2003-02-06 2004-08-19 Cipla Ltd Pharmaceutical compositions comprising immunosuppressants and uses thereof
JP2007516951A (ja) * 2003-12-30 2007-06-28 アステラス製薬株式会社 気道閉塞症の治療または予防のためのマクロライドの使用
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
WO2020122611A1 (ko) * 2018-12-11 2020-06-18 이화여자대학교 산학협력단 신규 화합물 및 이를 포함하는 발모 촉진용 조성물
KR102293890B1 (ko) * 2018-12-11 2021-08-27 주식회사 몰젠바이오 신규 화합물 및 이를 포함하는 발모 촉진용 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
CH677448A5 (el) * 1987-11-09 1991-05-31 Sandoz Ag
GB8802229D0 (en) * 1988-02-02 1988-03-02 Fujisawa Pharmaceutical Co Ws-9326 & its derivatives

Also Published As

Publication number Publication date
AU5721490A (en) 1991-01-07
DK0475994T3 (da) 1995-01-09
CA2054203C (en) 2001-08-21
IE902002L (en) 1990-12-06
EP0475994B1 (en) 1994-09-14
PT94292B (pt) 1997-01-31
DE69012560T2 (de) 1995-03-09
KR0147852B1 (ko) 1998-08-17
IE64214B1 (en) 1995-07-26
JP2508918B2 (ja) 1996-06-19
ES2061043T3 (es) 1994-12-01
ATE111353T1 (de) 1994-09-15
AU639460B2 (en) 1993-07-29
PT94292A (pt) 1991-02-08
KR920700638A (ko) 1992-08-10
CA2054203A1 (en) 1990-12-07
JPH05503283A (ja) 1993-06-03
GR900100428A (en) 1991-11-15
EP0475994A1 (en) 1992-03-25
DE69012560D1 (de) 1994-10-20
WO1990014826A1 (en) 1990-12-13

Similar Documents

Publication Publication Date Title
GR900100428A (en) Preparation method of compositions comprising macrocyclic compounds
DE3564941D1 (en) Dihydropyridazinones
PL309874A1 (en) Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives
DE69704057D1 (de) Terphenylverbindungen und sie enthaltende arzneimittel
GR3025207T3 (en) 2-Formylpyridine thiosemicarbazone derivatives, their preparation and their use as antitumor agents
AU1507888A (en) New bicyclic compounds, processes for preparation thereof and pharmaceutical composition comprising the same
AU3583989A (en) New cephem compounds and processes for preparation thereof
AU5754294A (en) Use of a pregnane derivative
TW339327B (en) Substituted benzoylguanidines, a process for their manufacture, their use as a medicament or diagnostic, as well as medicaments containing them
IE820896L (en) Trimethoxybenzenes.
TW336235B (en) 3'-aziridino-anthracycline derivatives, process for preparating them and pharmaceutical composition containing them
IE901314L (en) 2- substituted-n,n'-di(trimethoxybenzoyl)piperazines
HUT51623A (en) Process for producing pyrrole-indole derivatives and pharmaceutical preparations containing these ones as active substance
IE780926L (en) Chromene derivatives
AU655869B2 (en) An amphoteric tricyclic compound
ZA836090B (en) Thieno-thiazole derivatives,processes for preparing these compounds,and pharmaceutical compositions thereof
AU625238B2 (en) Anti-psychotic piperidylbenzimidazole compounds
JPS55122767A (en) Imidazole derivative*its manufacture and medical composition containing it
CA2150609A1 (en) Pyrimidine Derivatives and Pharmaceutical Composition
SE8603589L (sv) Metylendioxifenantren- och stilbenderivat
MY109729A (en) Benzofuranylimidazole derivatives, a process for the preparation and therapeutical compositions containing the same
MX9601163A (es) Nuevos compuestos derivados de cromeno.
EP0302633A3 (en) Beta-lactam compound, process for preparing the same, intermediate for synthesis of the same and medicinal composition for bacterially infectious disease therapy containing the same
AU657423B2 (en) Novel piperidine derivatives and process for preparation thereof
AU6014990A (en) New n-(23-vinblastinoyl) and n-(5'-noranhydro-23- vinblastinoyl) derivatives of 1-aminomethylphosphonic acid, process for preparing these and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees